Simrat Randhawa

EVP, Head of R&D

Simrat Randhawa (EVP, Head of R&D) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Dianthus Therapeutics, Inc. (DNTH). The largest single filing was $7.4M of DNTH (196,538 sh across 4 lots, as filed), executed Nov 13 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 4 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$15.0M

shares × price, as filed

Last traded

Sep 1

Filed Sep 3

Median ADV $122.5M across their filed names

Open performance→

Volume by month

Buys $0 Sells $15.0M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 4 filings

Sector per market data · by filing · past 12 months

Most traded names

DNTH

Dianthus Therapeutics, Inc. DNTH · 0 buys · 4 sells 4 filings

Recent filings

DNTHSALE Dianthus Therapeutics, Inc. View filing → $2.5M
23,124 sh across 3 lots
Exec Sep 1
Filed Sep 3 · 4:30 PM ET DNTHSALE Dianthus Therapeutics, Inc. View filing → $2.4M
26,530 sh across 3 lots
Exec Jun 1
Filed Jun 2 · 5:30 PM ET DNTHSALE Dianthus Therapeutics, Inc. View filing → $2.8M
33,830 sh × $81.48
Exec Mar 12
Filed Mar 13 · 5:30 PM ET DNTHSALE Dianthus Therapeutics, Inc. View filing → $7.4M
196,538 sh across 4 lots
Exec Nov 13 2025
Filed Nov 14 2025 · 5:30 PM ET